作者
Yun‐Fan Sun,Liang Wu,Yu Zhong,Kaiqian Zhou,Yong Hou,Zifei Wang,Zefan Zhang,Jiarui Xie,Chunqing Wang,Dandan Chen,Yaling Huang,Xiaochan Wei,Ying–Hong Shi,Zhikun Zhao,LI Yue-hua,Ziwei Guo,Qichao Yu,Liqin Xu,Giacomo Volpe,Shuang‐Jian Qiu,Jian Zhou,Carl Ward,Hui‐Chuan Sun,Ye Yin,Xun Xu,Xiangdong Wang,Miguel A. Esteban,Huanming Yang,Jian Wang,Michael Dean,Yaguang Zhang,Shiping Liu,Xin‐Rong Yang,Jia Fan
摘要
Hepatocellular carcinoma (HCC) has high relapse and low 5-year survival rates. Single-cell profiling in relapsed HCC may aid in the design of effective anticancer therapies, including immunotherapies. We profiled the transcriptomes of ∼17,000 cells from 18 primary or early-relapse HCC cases. Early-relapse tumors have reduced levels of regulatory T cells, increased dendritic cells (DCs), and increased infiltrated CD8+ T cells, compared with primary tumors, in two independent cohorts. Remarkably, CD8+ T cells in recurrent tumors overexpressed KLRB1 (CD161) and displayed an innate-like low cytotoxic state, with low clonal expansion, unlike the classical exhausted state observed in primary HCC. The enrichment of these cells was associated with a worse prognosis. Differential gene expression and interaction analyses revealed potential immune evasion mechanisms in recurrent tumor cells that dampen DC antigen presentation and recruit innate-like CD8+ T cells. Our comprehensive picture of the HCC ecosystem provides deeper insights into immune evasion mechanisms associated with tumor relapse.